We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+13.81%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$1.56B
Cap. Flow
+$702M
Cap. Flow %
6.71%
Top 10 Hldgs %
20.79%
Holding
1,751
New
156
Increased
901
Reduced
550
Closed
119

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$31.6M
2
APP icon
Applovin
APP
+$29.6M
3
MSFT icon
Microsoft
MSFT
+$26M
4
FTNT icon
Fortinet
FTNT
+$24.6M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$21.8M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Industrials 13.99%
3 Financials 11.83%
4 Consumer Discretionary 7.2%
5 Communication Services 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBG icon
1276
Corebridge Financial
CRBG
$14.1B
$411K ﹤0.01%
12,828
+855
+7% +$29.2K
HL icon
1277
Hecla Mining
HL
$10.2B
$407K ﹤0.01%
33,622
+77
+0.2% +$618
CIGI icon
1278
Colliers International
CIGI
$4.98B
$407K ﹤0.01%
2,604
+242
+10% +$37.2K
ARMK icon
1279
Aramark
ARMK
$15B
$406K ﹤0.01%
10,563
+145
+1% +$5.87K
AMBA icon
1280
Ambarella
AMBA
$2.99B
$405K ﹤0.01%
4,912
-124
-2% -$9K
KYMR icon
1281
Kymera Therapeutics
KYMR
$9.1B
$403K ﹤0.01%
7,116
-1,490
-17% -$67.2K
ASND icon
1282
Ascendis Pharma A/S
ASND
$16.7B
$402K ﹤0.01%
2,024
+736
+57% +$137K
FTAI icon
1283
FTAI Aviation
FTAI
$22.2B
$402K ﹤0.01%
2,410
+187
+8% +$26.6K
SRPT icon
1284
Sarepta Therapeutics
SRPT
$1.66B
$402K ﹤0.01%
+20,856
New +$372K
CMRE icon
1285
Costamare
CMRE
$1.9B
$402K ﹤0.01%
33,717
-15,209
-31% -$166K
TRI icon
1286
Thomson Reuters
TRI
$39.4B
$401K ﹤0.01%
2,543
+6
+0.2% +$1.12K
VSAT icon
1287
Viasat
VSAT
$9.79B
$398K ﹤0.01%
13,572
-1,052
-7% -$25.2K
BUR icon
1288
Burford Capital
BUR
$907M
$397K ﹤0.01%
33,158
+1,514
+5% +$20.2K
VOOG icon
1289
Vanguard S&P 500 Growth ETF
VOOG
$25.4B
$392K ﹤0.01%
5,406
IYW icon
1290
iShares US Technology ETF
IYW
$23.7B
$392K ﹤0.01%
1,999
+670
+50% +$123K
PSMT icon
1291
Pricesmart
PSMT
$5.75B
$391K ﹤0.01%
3,223
+348
+12% +$38.5K
UVV icon
1292
Universal Corp
UVV
$1.34B
$389K ﹤0.01%
6,971
-63
-0.9% -$3.48K
FCN icon
1293
FTI Consulting
FCN
$4.82B
$388K ﹤0.01%
2,403
-339
-12% -$56.3K
DGRO icon
1294
iShares Core Dividend Growth ETF
DGRO
$42.6B
$388K ﹤0.01%
5,703
ROIV icon
1295
Roivant Sciences
ROIV
$25.2B
$387K ﹤0.01%
25,596
-696
-3% -$8.62K
LRN icon
1296
Stride
LRN
$3.69B
$387K ﹤0.01%
2,599
-16
-0.6% -$2.35K
BMO icon
1297
Bank of Montreal
BMO
$125B
$386K ﹤0.01%
2,965
+77
+3% +$9.12K
SLAB icon
1298
Silicon Laboratories
SLAB
$7.15B
$386K ﹤0.01%
2,944
+738
+33% +$101K
CGNX icon
1299
Cognex
CGNX
$10.3B
$386K ﹤0.01%
8,520
-7,172
-46% -$290K
SOUN icon
1300
SoundHound AI
SOUN
$2.68B
$385K ﹤0.01%
23,965
-23,838
-50% -$316K

Similar funds

Vident Advisory's Q3 2025 Portfolio in Review

As of Q3 2025, Vident Advisory held 1,751 positions worth $10.5B, up 18% from $8.91B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Vident Advisory deployed $702M of net new capital in Q3 2025, opening 156 new positions and adding to 901 existing holdings. Its largest new stake was IonQ: 256,676 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palantir, an estimated $37.5M trimmed.

  • Vident Advisory's largest Q3 2025 buy was IonQ: 256,676 shares worth $15.8M.
  • Vident Advisory added most to Northrop Grumman in Q3 2025, an estimated $31.6M increase.
  • Vident Advisory's biggest Q3 2025 reduction was Palantir, cutting an estimated $37.5M.
  • Vident Advisory fully exited Rapid7 in Q3 2025, selling an estimated $4.8M.
  • Vident Advisory's ten largest holdings make up 21% of its $10.5B portfolio in Q3 2025.
  • Vident Advisory opened 156 new positions and closed 119 in Q3 2025.
  • Vident Advisory's portfolio value rose 18% quarter-over-quarter to $10.5B.

Based on Vident Advisory's 13F filing for Q3 2025, filed 14 Nov 2025.